C
Novo Nordisk A/S NVO
$54.46 $0.160.30% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 24.06% 15.82% 20.61% 27.14% 37.16%
Total Depreciation and Amortization 40.67% 6.10% -9.01% -5.28% 8.89%
Total Amortization of Deferred Charges 18.52% 18.52% 18.52% 14.80% 14.80%
Total Other Non-Cash Items 47.09% 302.89% -17.55% 43.66% -58.28%
Change in Net Operating Assets -2,148.18% -46.21% 7.28% -706.06% 104.61%
Cash from Operations 6.93% 39.31% 11.11% 11.55% 31.45%
Capital Expenditure -65.74% -74.13% -82.46% -91.96% -86.66%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -11,983.50% -- -- 90.08% 90.08%
Divestitures -- -- -- -- --
Other Investing Activities 144.40% -51.64% 101.63% 22.54% -12.73%
Cash from Investing -196.96% -314.30% -190.78% -23.89% -32.43%
Total Debt Issued 240.38% -- -- 36,354.74% 52,996.92%
Total Debt Repaid -1,200.60% -1,282.08% -331.83% -368.34% -335.35%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 56.91% 32.03% 32.56% 18.96% -0.02%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -18.84% -18.84% -40.21% -40.21% -55.16%
Other Financing Activities -- 1,008.73% -- -- --
Cash from Financing 35.92% 157.07% 112.20% 36.00% 26.10%
Foreign Exchange rate Adjustments -294.17% 62.40% 485.36% 32.55% 141.94%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -213.65% 482.86% -12.51% 841.37% 4,664.26%